Related Experiment Video
Updated: Aug 15, 2025
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
4.1K
Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management
Zhiyong Du1,2, Yanwen Qin1,2
1The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Journal of Clinical Medicine
|January 8, 2023
Insights
Cardiovascular disease, a global health crisis, is significantly driven by dyslipidemia. This research explores key factors contributing to cardiovascular morbidity and mortality worldwide.
Area of Science:
- Cardiology
- Metabolic Disorders
- Public Health
Background:
- Cardiovascular disease (CVD) remains the primary cause of global mortality.
- Dyslipidemia is a critical, modifiable risk factor for CVD development.
- Understanding the interplay between dyslipidemia and CVD is essential for public health strategies.
Discussion:
- This study investigates the complex relationship between lipid profiles and cardiovascular outcomes.
- Analysis focuses on identifying specific dyslipidemic patterns associated with increased morbidity and mortality.
- The findings highlight the urgent need for effective management of lipid disorders.
Key Insights:
- Dyslipidemia significantly elevates the risk of cardiovascular events and mortality.
- Early detection and intervention in dyslipidemia can mitigate CVD burden.
- Global health initiatives must prioritize lipid management for cardiovascular health.
Outlook:
- Further research into novel therapeutic targets for dyslipidemia is warranted.
- Long-term studies are needed to evaluate the impact of interventions on CVD reduction.
- Integrating comprehensive lipid management into primary care can improve patient outcomes.
Abstract:
Cardiovascular disease is the leading cause of morbidity and mortality worldwide, and dyslipidemia is one of the major risk factors [...].
Related Concept Videos
01:26Atherosclerosis III: Management
19
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
745
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
745
01:26Coronary Artery Disease IV: Preventive Measures
31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
01:26Angina IV: Management
14
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
14
01:30Coronary Artery Disease I: Introduction
46
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
01:18Lipids: Dietary Sources and Requirements
906
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
906